图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
真核基因表达评论综述™
影响因子: 1.841 5年影响因子: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN 打印: 1045-4403
ISSN 在线: 2162-6502

真核基因表达评论综述™

DOI: 10.1615/CritRevEukaryotGeneExpr.2015013843
pages 203-207

Dual Protective and Cytotoxic Benefits of Mesenchymal Stem Cell Therapy in Combination with Chemotherapy/Radiotherapy for Cancer Patients

Fatemeh Hendijani
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
Shaghayegh Haghjooy Javanmard
Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

ABSTRACT

Cancer is a major health problem in the world, and scientists seek innovative treatment strategies with higher efficacy and lower toxicity than the existing therapeutic agents. In this way, stem cell researchers try to reveal new pathways that will eventually benefit patients. Stem cell research has proven that mesenchymal stem cells (MSCs) possess anticancer activities, and their protein-rich secretome showed similar effects. MSCs also secrete cytokines that play an active role in healing and regeneration processes. Because of their known plasticity, MSCs display a variety of characteristics and functions in different environments, depending on their interactions with various cell types and tissues. Therefore, we hypothesize that MSC therapy in combination with anticancer medicines can potentiate cytotoxic effects on cancer cells. In addition, because of their regenerative capacity, MSCs can protect normal tissues from adverse cytotoxic drug reactions. They may also help rescue injured tissues from these toxic damages or systemic pathological events that occur during cancer treatment. MSC therapy may double the beneficial effects on cancer and normal cells. As our knowledge of systems biology and biotechnological methodology is progressing, this idea can move forward as a treatment option.


Articles with similar content:

Seven Key Principles of Cancer Therapy: Alternative Approaches to Disease Resolution
Forum on Immunopathological Diseases and Therapeutics, Vol.3, 2012, issue 3-4
Subrata Chakravarty, Antonio Jimenez
Scaffold-Free Spheroids Derived from Stem Cells for Tissue-Engineering Applications
Critical Reviews™ in Biomedical Engineering, Vol.46, 2018, issue 5
Pradnya M. Salve, Kaushik U. Desai, Neha B. Sapkal, Jay R. Dave, Geetanjali B. Tomar
Cancer Stem Cells in Urooncology
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 1
Cag Cal, Zeynep Yuce
The Role of the Lkb1/AMPK Pathway in Hematopoietic Stem Cells and Leukemia
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 5
Daisuke Nakada, Yusuke Saito
Adipose-Derived Stromal Vascular Fraction Cells: Update on Clinical Utility and Efficacy
Critical Reviews™ in Eukaryotic Gene Expression, Vol.25, 2015, issue 2
Ki-Chul Hwang, Hyun Min Sun, Seongho Han, Sung-Whan Kim